The PETRUSHKA platform uses clinical data and patient-reported side-effect priorities to rank antidepressant options and guide shared treatment decisions.
Participants receiving digital cognitive behavioral therapy had higher remission rates and lower anxiety severity than those assigned to psychoeducation
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.